Pertuzumab and Trastuzumab Combination with Concomitant Locoregional Radiotherapy for the Treatment of Breast Cancers with HER2 Receptor Overexpression

SIMPLE SUMMARY: This retrospective study demonstrates that the combination of locoregional breast RT with dual HER2 blockade by pertuzumab/trastuzumab was very well tolerated, suggesting that RT can be safely administered to patients with HER2-positive breast cancer during dual HER2 blockade. Excell...

Descripción completa

Detalles Bibliográficos
Autores principales: Aboudaram, Amélie, Loap, Pierre, Loirat, Delphine, Dhia, Syrine Ben, Cao, Kim, Fourquet, Alain, Kirova, Youlia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507738/
https://www.ncbi.nlm.nih.gov/pubmed/34638275
http://dx.doi.org/10.3390/cancers13194790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507738/
https://www.ncbi.nlm.nih.gov/pubmed/34638275
http://dx.doi.org/10.3390/cancers13194790

Ejemplares similares